BTA biota holdings limited

gsk to increase to 160 million packs pa , page-8

  1. 221 Posts.
    its now on wall street journal as well

    The firm is also ramping up production for relenza, a drug that can be used to treat the H1N1 flu, and will be capable of producing about 60 million packs a year in eight weeks.

    "Governments are really keen to build more stockpiles of relenza than they have in the past for various reasons," Witty said. "We're also talking to regulators about a second form or delivery system for relenza, which will also massively increase capacity."


    http://online.wsj.com/article/BT-CO-20090609-700317.html


    this is what i like the most "Governments are really keen to build more stockpiles of relenza than [B] they have in the past for various reasons [/B]"
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.